T1	Participants 133 156	advanced ovarian cancer
T2	Participants 159 267	From May 1978 until November 1980, 169 previously untreated patients with advanced epithelial ovarian cancer
T3	Participants 570 605	153 patients evaluable for response
T4	Participants 1102 1137	158 patients evaluable for survival
